<DOC>
	<DOC>NCT02431832</DOC>
	<brief_summary>An open-label, one-sequence, multiple administration study for exploration of microRNA and metabolomics biomarkers to predict drug induced liver injury in healthy elderly Korean people.</brief_summary>
	<brief_title>Exploration of microRNA and Metabolomics Biomarkers Predicting Drug Induced Liver Injury in Elderly People</brief_title>
	<detailed_description />
	<mesh_term>Drug-Induced Liver Injury</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<criteria>Healthy subjects, as determined by medical history, physical examination, 12lead electrocardiogram (ECG), and clinical laboratory evaluations were eligible to participate in the study. Subjects had to be 65 to 84 years of age. Subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor Subject judged not eligible for study participation by investigator</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Elderly</keyword>
</DOC>